Compare OKYO & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OKYO | FNWB |
|---|---|---|
| Founded | 2007 | 1923 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.7M | 87.5M |
| IPO Year | 2022 | 2015 |
| Metric | OKYO | FNWB |
|---|---|---|
| Price | $2.17 | $10.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 252.8K | 52.8K |
| Earning Date | 07-18-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $54,052,000.00 |
| Revenue This Year | N/A | $31.86 |
| Revenue Next Year | N/A | $10.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $0.90 | $6.05 |
| 52 Week High | $3.35 | $12.10 |
| Indicator | OKYO | FNWB |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 68.78 |
| Support Level | $1.97 | $9.59 |
| Resistance Level | $3.20 | $10.98 |
| Average True Range (ATR) | 0.30 | 0.30 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 17.80 | 80.65 |
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.